Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Adverum Biotechnologies, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 61 | 68 | +7 |
| Shares | 16.8M | 17.9M | +1.11M (+6.6%) |
| Value | $236.9M | $117.7M | −$119.2M (−50.3%) |
New holders (20)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 396,931 | $2.72M | 0.00% |
| Soleus Capital Management, L.P. | 147,246 | $1.01M | 0.09% |
| Citadel Advisors LLC | 125,790 | $862.9K | 0.00% |
| Nuveen Asset Management, LLC | 68,537 | $470.2K | 0.00% |
| Bank of New York Mellon Corp | 64,585 | $443.1K | 0.00% |
| Jane Street Group, LLC | 29,202 | $200.3K | 0.00% |
| Jump Financial, LLC | 24,203 | $166.0K | 0.00% |
| Bank of Montreal | 16,242 | $129.9K | 0.00% |
| New York State Common Retirement Fund | 14,400 | $98.8K | 0.00% |
| Graham Capital Management, L.P. | 11,782 | $80.8K | 0.00% |
| Corebridge Financial, Inc. | 11,192 | $76.9K | 0.00% |
| Bayesian Capital Management, LP | 10,756 | $73.8K | 0.01% |
| MetLife Investment Management | 5,493 | $37.7K | 0.00% |
| Ameritas Investment Partners, Inc. | 2,038 | $14.0K | 0.00% |
| Legal & General Group Plc | 1,797 | $12.3K | 0.00% |
| California State Teachers Retirement System | 1,507 | $10.3K | 0.00% |
| BNP Paribas Arbitrage, SA | 1,497 | $10.3K | 0.00% |
| Amalgamated Bank | 720 | $5.00K | 0.00% |
| Simplex Trading, LLC | 322 | $2.00K | 0.00% |
| Frazier Financial Advisors, LLC | 1 | $7 | 0.00% |
Sold out (13)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Commodore Capital LP | 657,333 | $9.29M |
| Laurion Capital Management LP | 438,935 | $6.21M |
| Samsara BioCapital, LLC | 291,666 | $4.12M |
| AIGH Capital Management LLC | 162,547 | $2.30M |
| Newtyn Management, LLC | 46,189 | $653.1K |
| Marathon Trading Investment Management LLC | 28,340 | $400.7K |
| Shay Capital LLC | 23,395 | $330.8K |
| Walleye Capital LLC | 16,369 | $231.5K |
| Balyasny Asset Management LLC | 14,198 | $200.8K |
| Point72 Asia (Singapore) Pte. Ltd. | 9,276 | $131.2K |
| Cubist Systematic Strategies, LLC | 8,483 | $119.9K |
| Acadian Asset Management LLC | 2,902 | $41.0K |
| Macquarie Group Ltd | 2,586 | $37 |